SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004386
Filing Date
2019-04-01
Accepted
2019-04-01 08:31:37
Documents
86
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1240024
2 ex10-12.htm EX-10.12 477706
3 image_001.jpg GRAPHIC 1275
4 ex21-1.htm EX-21.1 4135
5 ex23-1.htm EX-23.1 5121
6 ex31-1.htm EX-31.1 11645
7 ex31-2.htm EX-31.2 11674
8 ex32-1.htm EX-32.1 12931
  Complete submission text file 0001493152-19-004386.txt   5596218

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE cocp-20181231.xml EX-101.INS 780859
10 XBRL SCHEMA FILE cocp-20181231.xsd EX-101.SCH 50946
11 XBRL CALCULATION FILE cocp-20181231_cal.xml EX-101.CAL 66139
12 XBRL DEFINITION FILE cocp-20181231_def.xml EX-101.DEF 223264
13 XBRL LABEL FILE cocp-20181231_lab.xml EX-101.LAB 382459
14 XBRL PRESENTATION FILE cocp-20181231_pre.xml EX-101.PRE 334117
Mailing Address 1860 MONTREAL ROAD TUCKER GA 30084
Business Address 1860 MONTREAL ROAD TUCKER GA 30084 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38418 | Film No.: 19718887
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences